Here are four programs making a difference.
Here are healthcare leaders’ top challenges, as well as coping strategies
Leadership skills honed in midst of disaster.
Strategies to get the most value out of current and future oncology payment models
Increasing chronic care needs are incentivizing direct-tech services.
Here are the top drugs expected to be approved this year and their financial impact.
Payer education, evidence critical to providing cost-effective, beneficial treatment in pharmacogenetics.
The new and proposed federal regulations, as well as state laws, that are trending across the United States.
Many of the challenges that face our industry in 2020 will require a fresh way of thinking.